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Abstract
What determines success on Wall Street? This study examined if genes affecting dopamine levels of professional traders
were associated with their career tenure. Sixty professional Wall Street traders were genotyped and compared to a control
group who did not trade stocks. We found that distinct alleles of the dopamine receptor 4 promoter (DRD4P) and
catecholamine-O-methyltransferase (COMT) that affect synaptic dopamine were predominant in traders. These alleles are
associated with moderate, rather than very high or very low, levels of synaptic dopamine. The activity of these alleles
correlated positively with years spent trading stocks on Wall Street. Differences in personality and trading behavior were
also correlated with allelic variants. This evidence suggests there may be a genetic basis for the traits that make one a
successful trader.
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Introduction
Financial market volatility is often attributed to institutional
traders who are ‘‘cowboys,’’ taking risky positions that result in
market paroxysms [1–3]. By one estimate, professional traders
were responsible for only 10% of New York Stock Exchange
(NYSE) trading volume in the 1960’s, while individual investors
were the primary source of trades. Professional trades are
estimated to account for 90% of NYSE activity today, with
traders from the 100 largest institutions responsible for 75% of
volume [4]. At the same time, stock market prices are known to
exhibit ‘‘excess volatility’’ [5], that is, to move more than predicted
by the economic fundamentals of companies they represent. The
reasons for excessive market volatility are unresolved, but the high
volume of institutional trades suggests it is at least partially due to
the behavior of professional stock traders [1,5–8] Understanding
the behavior of traders is especially important in light of calls for
increased regulation of financial markets after the rapid 48%
decline in the NYSE in 2008. Recent research has shown that
physiologic factors affect financial decisions. For example, Apicella
et al. (2008) found that levels of testosterone in saliva were
associated with greater risk-taking in a laboratory investment game
[9]. Field studies have also highlighted this relationship, demon-
strating that when professional traders trade in volatile markets
they have increased cardiovascular tone [10], and that morning
testosterone levels predict professional traders’ daily profits [11].
Both prenatal and circulating testosterone appear to influence the
choice of a financial career and success in this field as measured by
longevity [12,13].
The biological factors affecting financial decisions may have a
genetic basis. Analyzing data from Swedish twins, 29 percent of
the variation in the decision to invest in stocks can be attributed to
genetics [14]. Data from twins who are investment professionals
showed that approximately 25 percent of portfolio risk is due to
one’s genes [15]. This research is tantalizing because it points
towards genes affecting financial behaviors; yet it does not indicate
the genes that cause differences between individuals. Our
approach was to fill this gap by identifying specific genes in
individuals who are making significant financial decisions on a
daily basis. Understanding how biology affects financial decisions
may have policy implications as the U.S. grapples with additional
regulation of financial institutions.
In the present study we genotyped 60 New York City
professional stock traders (those who execute trades in stock
markets) at five different companies during the summer of 2008.
All samples were obtained before the prodigious stock market
decline that began August 28, 2008 that destroyed several large
money management companies. Studying Wall Street profession-
als can be difficult because of the lavish value of their time and
their high turnover, especially among short-tenure traders. In this
study, we targeted traders who were successful; that is, those who
on average have survived the ups and downs of Wall Street for
nearly a decade. The majority of the traders assessed were
intermediary traders who bought and sold securities for clients
rather than on behalf of the companies for whom they worked.
Rather than measure personality traits of traders [16] or study
college students making low-stakes decisions in a laboratory [17],
we investigated whether a set of functional genetic polymorphisms
associated with brain function would predispose one to be
successful on Wall Street. In particular, we were interested in
determining whether frequencies of certain alleles would differ
between traders and controls. We investigated two regions in the
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30844dopamine receptor 4 gene, one region in the catecholamine-O-
methyltransferase gene (COMT), a region in the monoamine
oxidase A gene (MAO-A), and the promoter region in the
serotonin gene (SERT). These genes were selected because of their
relationship to risk-taking and mood. Dopamine in particular has
been associated with financial decision-making in functional MRI
(fMRI) studies of financial decisions [18,19]. Genes map more
directly onto the traits that may make traders successful than do
brain imaging studies that characterize the state of brain activity
during a particular task. Yet, findings from neuroeconomics
studies [20] coupled with methods for reducing the genomic
search space in genetic association studies guided our choices of
candidate genes. Successful traders have to balance risk-return
trade-offs throughout the day. At the same time, stock traders have
to execute trading rules while maintaining discretion when
unforeseen opportunities present themselves. This requires
modulating attention, novelty seeking, learning, and impulsivity.
We hypothesized that sustaining the balance between rules and
discretion would be associated with a particular combination of
genes and alleles that affect brain function.
Levels of synaptic dopamine have an inverted-U relationship
with several cognitive abilities as shown by both animal and
human data [21]. For example, markedly low or high levels of
dopamine are associated with disruptions in working memory,
while moderate levels of dopamine are associated with improved
memory [22]. Densities of D2 and D3 dopamine receptors also
have an inverted-U association with sensation seeking [23] and
risk-taking can be increased by administration of the dopamine
agonist pramipexole [24]. Evidence from Parkinson’s disease
patients also shows an association between treatment with
dopamine agonists and risk-taking and impulse control disorders
[25,26]. Adolescents, who have fewer dopamine receptors and
reduced synaptic dopamine compared to adults, show elevated
risk-taking compared to pre- or post-adolescents [27–29]. Since
successful trading depends on appropriate amounts of risk-taking
and engaging cognitive control, we hypothesized that successful
traders would have genes that produce intermediate levels of
synaptic dopamine.
Materials and Methods
Participants
A total of 60 traders from five Wall Street firms and 54 graduate
students from the Claremont Graduate University in Southern
California participated in the study. The trader population
consisted of 54 males and six females. The anonymity of
participants was maintained throughout, with the data we
collected in New York City in July, 2008. The companies who
agreed to make their employees available to us traded high
volumes of equities, fixed income instruments, and derivatives for
both clients and their own proprietary trading books. The controls
consisted of 44 males and 10 females who were students at
Claremont Graduate University, producing a total sample size of
114. These data were collected in September, 2008 from the lobby
of the Claremont Graduate University’s Peter F. Drucker-
Masatoshi Ito Graduate School of Management over several
evenings when MBA courses were ending. We targeted MBA
students in order to recruit controls who were interested in
business, but were not professional traders. All participants
provided written informed consent, and the study protocol was
approved by the Institutional Review Board at Claremont
Graduate University. Saliva samples were collected from all
participants using the OrageneH DNA kit (DNA Genotek Inc,
Ontario, Canada) and genomic DNA was purified according to
manufacturer’s specifications. The concentration and purity of
each DNA sample was determined using a Nanovue spectropho-
tometer (GE LifeSciences, Piscataway, NJ, USA).
Genetic Targets
Our approach was to look for a set of genetic alleles active in the
brain that may affect success in finance. As mentioned above, we
focused on genes that affect the activity of the neurotransmitter
dopamine (DA), because a large number of neuroeconomics
studies have demonstrated that DA influences financial decision-
making. Functional MRI (fMRI) studies have associated activation
in dopamine-receptor-rich ventral striatal regions in the brain with
the anticipation of financial gains [19,30]. These studies indicate
DA is associated with financial decision-making.
Two recent studies of financial decisions in the laboratory have
associated variations in the dopamine receptor 4 (DRD4) gene
with greater risk-taking by college students [31,32]. DRD4, a G-
protein coupled receptor located on chromosome 11, contains two
distinct repeat polymorphisms designated the promoter insertion/
deletion (DRD4P) and the exon III (DRD4e3) variable number of
tandem repeats (VNTR) [33]. College-aged participants who had
7 or more VNTRs in DRD4e3 region took more risk than those
with less than 7 repeats. The DRD4P region contains two alleles, a
long allele (L) and a short allele (S), with the length of the allele
inversely associated with DRD4 transcription levels [34]. Alleles
associated with a decrease in DRD4 activity in the prefrontal
cortex have been associated with novelty seeking, attention deficit
hyperactivity disorder, and substance abuse [35–37]. The effect of
DRD4P on financial decisions has not been previously reported.
Genetic variation in genes altering dopamine activity may also
influence financial decision-making. The COMT gene is involved
in the catabolism of dopamine in the frontal cortex and the ventral
striatum. This gene contains a coding region single nucleotide
polymorphism (SNP) within exon 4 in which codon 158 may be
either a valine (Val) or a methionine (Met) [38]. The methionine
variant has lower enzymatic activity than the valine version
resulting in higher synaptic DA. Individuals who are homozygous
for the Met allele (denoted A/A) exhibit only 25% of the
enzymatic activity compared to individuals homozygous for the
Val allele (G/G) [38]. The low activity Met allele has been
associated with reduced levels of phasic dopamine in subcortical
regions [39]. Several studies have found that G/G individuals
perform better than those with the A/A allele on tasks demanding
cognitive flexibility, while individuals with the A/A allele are
better at tasks demanding focused attention [40-43]. Additionally,
A/A individuals show higher loss aversion behavior, decreased
impulsivity and reduced novelty seeking [44–46].
Monoamine oxidase (MAO) is also involved in the catabolism of
dopamine, and allelic variants of the MAO-A gene have been
associated with sympathetic arousal and anxiety that may affect
financial decision making [47–49]. Two recent studies investigated
financial decisions and MAO-A variants. The 3 VNTR allele has
low enzymatic activity that produces higher levels of synaptic DA.
Conversely, the 4 VNTR variant has higher activity, resulting in
lower levels of DA. The low DA (4 VNTR) allele has been
associated with a preference for long-shot risks and to a lower
likelihood of obtaining protective insurance [50]. Another study
reported that those with the high DA (3 VNTR) MAO-A allele
had an increased likelihood of taking an advantageous financial
risk [51].
Serotonin (5-HT) is well known for its effect on anxiety and
mood [52-54]. The promoter region of the serotonin gene, called
5HTTLPR or SERT, has two alleles, short (S) and (L) with
serotonin activity higher for the L variant. The S allele is
Genes Predict Success on Wall Street
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often associated with vigilance and fear [55]. SERT has been
associated with risk preference, with those homozygous for the
short version of the allele (S) exhibiting 28% less risk-taking than
those with S/L or L/L variants [32]. Those homozygous for the S
allele show greater loss aversion and take fewer financial risks
[56,57]. Using a similar methodology, a recent study found no
relationship between SERT alleles and risk propensity [51].
Genotyping
Genotyping was performed by PCR as previously described
[58]. A subset of the genotypes was independently verified by
DNA sequencing of the PCR products at UC Davis Sequencing
Core (Davis, CA). Genotyping for the COMT Val158Met (G/A)
SNP was performed by tetra-ARMS PCR as described in Ruiz-
Sanz, Aurrekoetxea, del Agua, & Ruiz-Larrea (2007) [59].
Genotyping for the DRD4 exon III VNTR and MAO-A promoter
VNTR was performed at the UCLA Genotyping Core (Los
Angeles, CA). The genotyping failure rates were 1% for the DRD4
exon III VNTR, 1.8% for the MAO-A promoter VNTR, 1% for
the DRD4P, and 2.6% for the COMT G/A SNP.
2.4 Statistical Analysis
Genotype frequencies for the two biallelic polymorphisms
(DRD4P and COMT Val158Met SNP) were tested for Hardy-
Weinberg Equilibrium (HWE) in the controls using both chi-
squared and Fisher’s exact test (both results were consistent, only
chi-squared is reported). Genotype frequencies for the multiallellic
DRD4 exon III VNTR were tested for Hardy-Weinberg
Equilibrium in the control group using the Markov-chain
algorithm [60]. The MAO-A promoter VNTR is an X-linked,
multiallelic polymorphism; therefore, testing for Hardy-Weinberg
Equilibrium was performed only in the female controls as
described in Philibert, Gunter, Beach, Brody, & Madan (2008)
[61]. The genotype frequencies of all the polymorphisms were in
Hardy-Weinberg Equilibrium in the control sample (DRD4 VNT:
p=0.47; DRD4P: p=.21; COMT: p=0.16; MAO-A: p=0.62).
Distributions of the genotypes also matched those described
previously for similar samples [31,32,51,58,62,63].
Testing for association in traders and controls with the DRD4
promoter insertion/deletion, and COMT G/A (Val158Met) SNP
was performed using logistic regression and assuming a dominant
genetic model for the DRD4 l (long) and COMT A (Met) alleles,
respectively, as described in Balding (2006) [64]. Testing for
association with the SERT promoter VNTR was performed by
excluding individuals with 1 or more copies of the rare SERT
alleles as described above, and treating the polymorphism as
biallelic in the remaining population (54 traders and 52 controls).
Association was tested using logistic regression and assuming a
dominant genetic model for the s (short) allele also as described in
Balding (2006) [64]. We tested for association with the X-linked
MAO-A promoter VNTR by first excluding heterozygous females
and performing the analysis on the remaining subjects, males and
homozygous females as described in Fossella et al. (2002) [65],
using a codominant genetic model for the 3R and 4R alleles (3 and
4 repeat alleles respectively). Association with the multiallelic
DRD4 exon III VNTR was performed by classifying genotypes by
the number of copies of the 7R allele (7 repeat) and subsequently
using logistic regression assuming a dominant genetic model for
the 7R allele as described in Kuhnen and Knutson (2005) [17]. We
additionally tested for association by grouping the 2R and 7R
alleles, as there is biochemical evidence these alleles confer
diminished biological activity to the DRD4 protein [66]. We
subsequently classified genotypes according to the number of
copies of the 2R or 7R alleles for logistic regression analysis.
Neither approach showed a statistically significant association.
Confidence intervals (CI) were computed using logistic regression.
All tests for association were performed using a significance level of
p,0.05.
Dopamine activity assignments were based on research cited
above. These were COMT: GG=0 GA=1 AA=2; DRD4P:
LL=0, LS=1, SS=2. The DA index simply summed each of
these values to create an overall DA index. We developed this
approach as a simple and direct measure to assess the combination
of genes on behavior.
Results
The average age of the trader sample was 35.4 years (SD 7.3;
range=22–51) and the average number of years of professional
trading experience was 9.2 (SD 7.0; range=1–26). The average
years of experience did not vary by firm. The average age of the
control sample was 32.4 years (SD=10.6; range=22-69), and this
did not differ significantly from the age of the trader sample
(p=.09). Removing the 69 year old participant does not change
the results so this participant was not excluded.
Genetic analysis
The DRD4e3 2R, 4R and 7R VNTRs were observed at the
highest frequencies (.10%), with other alleles (3R, 5R, 8R and
10R) occurring at frequencies , 10% in the traders and controls.
We classified subjects as carriers or non-carriers of the 7R allele as
done in previous studies [31,32]. Twenty-nine percent of traders
had the 7R allele, while 24 percent of controls carried this VNTR.
This difference was not significant (chi-squared test, p=0.61).
For DRD4P, we classified subjects as carriers or non-carriers of
the S allele. Since the S allele is associated with increased
expression of DRD4 mRNA [34], S carriers are expected to have
higher levels of DRD4 mRNA and higher receptor levels than
non-carriers (L/L individuals). We found that more traders were
homozygous for the L allele compared to controls (70% vs. 53%)
and that traders were nominally less likely to be S carriers than
controls (30% vs. 47%; chi-squared test, p=0.06).
For the COMT SNPs, we categorized those with A/A as having
higher synaptic dopamine (H) than those in the G/G or A/G
lower COMT activity (L) group. Traders were significantly more
predominate in the H group (31%) relative to controls (13%) (chi-
squared test, p=0.019; Fig. 1).
We also tested whether variants of the MAO-A gene were more
predominant in traders. We found no significant difference
between traders and controls for the 3 VNTR versus 4 VNTR
alleles (chi-squared test, p=0.44). In addition, there was no
difference between traders and controls for the L and S alleles of
the serotonin promoter region, SERT (chi-squared test p=.90).
Next, we examined whether combinations of genetic polymor-
phisms might be more frequent in traders relative to controls. We
found a statistically significant COMT X DRD4P interaction (F
test, p=0.014). This interaction shows that traders are more likely
to have the H COMT allele and have at least one S allele for
DRD4P. No other combinations of polymorphisms resulted in a
significant interaction.
Years working on Wall Street
It is difficult to gauge an individual trader’s success based on
portfolio performance because returns depend on overall activity
in the stock market, growth of the economy, as well as the quality
of their company’s research. We therefore used years working as a
measure of success as a trader since low performing traders are
Genes Predict Success on Wall Street
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Although this definition may not encompass all aspects of success,
it provides a consistent measure of performance and has previously
been used [12]. To assess the relationship between genetic
polymorphisms and years working on Wall Street, we assigned
values to each allele for synaptic DA activity (see Methods). We
Figure 1. Professional traders were 36% less likely to carry the high activity S allele of the DRD4P gene than were controls
(Professionals: 30%, Controls: 47%; P=.06). Traders had the high activity A/A COMT allele 138% more than controls compared to the lower
activity A/G or G/G alleles (Professionals: 31% A/A; Controls: 13% A/A; P=.019).
doi:10.1371/journal.pone.0030844.g001
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trader. COMT associated DA levels had a positive and significant
correlation with success as a trader (r=.19, one-tailed t-test,
p=.05); Fig. 2. Neither DRD4P (one-tailed t-test, p=.93) nor
DRD4e3 (one-tailed t-test, p=.95) were associated with years
trading.
To investigate the relationship between DRD4P, COMT, and
success on Wall Street more fully, we constructed a linear index
based on the amount of synaptic dopamine each allelic
combination would produce (see Methods). Performing and 80–
20 split, we found that that those with 15 or more years on Wall
Street had a DA index 35% higher than those who had spent less
time trading professionally (DA index long tenure mean=1.80,
short tenure mean=1.33; F=3.02, p=.04; Fig. 2). We also found
that those with the highest scores on the DRD4P index were less
likely to trade in volatile markets, based on self report, than traders
with lower DA levels (r=2.30, one tailed t-test, p=.01).
Personality traits
A subset of 25 traders completed the Myers-Briggs Type
Indicator (MBTI) to measure their personality traits. We included
this analysis to map the genotype of successful traders into a
phenotype. There was no difference between those who completed
the MBTI and those who did not for gender, age, or years traded
(t-tests, p..20), indicating that this subsample is representative of
the larger sample of traders. The MBTI is a standard test of
personality based on four dichotomous categories that correlate
with the ‘‘big five’’ personality groupings [67]. We were
specifically interested in the distribution of the fourth category in
the MBTI, Judging (J) or Perceiving (P), as this dimension is
thought to represent how much organization one prefers in life.
Those who are the J type typically carefully plan their lives, while
those who are the P type tend to keep their options open [68]. In
the trader sample, 44% had the Judging (J) personality type and
56% were the Perceiving (P) type. We expected that more
successful traders would be type P, as individuals with this
personality type tend to do significant analysis before making
decisions. The P personality type in the U.S. population is
estimated to be 46% [69], though the trader sample is not
significantly different than this value (binomial test, p=.21). We
found that the P personality type had a 50% higher score on the
DA index than did traders of the J type (mean J=1.09; mean
P=1.64; one-tailed t-test, p=.036). We did not find differences for
any of the other MBTI types.
Genetics also affected outlook on the world. Traders with the
high activity COMT allele and those who scored higher on the
overall DA index were less likely to view the world in terms of
‘‘survival of the fittest’’ (COMT index: r=2.38, two-tailed t-test,
p=.004; DA index: r=2.30, two tailed t-test p=.027).
Discussion
Our primary finding is that two genetic alleles that affect DA are
associated with success at trading stocks on Wall Street. We
showed that alleles of COMT and DRD4P were predominant in
traders compared to controls, and we also demonstrated that a
combination of these alleles were associated with being a trader.
Both COMT and DRD4P affect the brain’s synaptic levels of
dopamine. Several neuroeconomics studies of financial decisions
have shown that activity in the dopaminergic nucleus accumbens
predicts risk-taking [18]. It is possible that the successful traders in
our sample who had genes associated with moderate synaptic
dopamine may be predisposed to take an appropriate level of risk,
but not too much, thereby contributing to their success. This was
evidenced by their reduced reports of trading in volatile markets.
Using years on Wall Street as a measure of success, we found a
positive correlation between success as a trader and a combination
of alleles that are associated with intermediate levels of synaptic
DA. We did not find that traders were more likely to carry the 7R
variant of the DRD4e3 VNTR, an allele associated with risk-
taking in two laboratory studies. Our results suggest that successful
traders in our sample weigh risk and reward, rather than taking
excessive risks. This was born out in the personalities of our sample
of traders. We found that they were good at integrating disparate
Figure 2. Years working as a trader correlates with DA levels as determined by COMT alleles (r=.19.0, one-tailed t-test P=.05).
Those with the lowest COMT-related synaptic DA category (G/G) averaged 6.5 years of trading experience, while those in the highest category (A/A)
averaged 10.6 years trading stocks (one tailed t-test P=.05).
doi:10.1371/journal.pone.0030844.g002
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did not view the world as threatening their survival. These findings
align with previous evidence suggesting that more experienced
traders may respond in a less emotional way than those with less
experience [10]. Nevertheless, other studies of professional traders
have found that they are susceptible to trading biases [70–72].
We also examined two other genetic targets that affect DA levels
and personality traits: MAO-A and SERT. We found no
significant difference in the frequency of MAO-A or SERT alleles
in traders compared to controls. This is potentially problematic,
given that other studies have linked SERT and MAO-A to
financial risk-taking tendencies; however, these results have been
inconsistent [51,56,57].
It is important to note that our observations come from a
relatively small sample. High income individuals recruited at work,
such as the Wall Street traders, are difficult to access for data
collection, which is the reason for the small sample at hand. It is
therefore important that the results reported here are replicated.
Additionally, our sample of traders may not include some of the
most successful professionals who have the opportunity to leave the
types of major companies from which we drew our data for early
retirement or to begin their own company. We opted to define
successful trading by longevity because this information could be
reliably collected and because this is a measure also used in
previous research [12]; however, other definitions of success may
be considered more informative and should be examined in the
future.
Our findings can contribute to discussions of changes in the
regulation of finance professionals and asset markets in the wake of
the 2008 recession. Our results suggest that using a history of risk-
taking and competitive behaviors when hiring traders could be a
mistake, though this is often done [73]. Having too little or too
much risk-aversion is not associated with success by those in our
sample; rather taking a balanced level of risk appears to be
optimal. Further, our findings indicate the importance of training
the dopamine system to accurately assess risk and reward in the
context of trading. The balancing of risk and reward is essential to
successful trading, but trading on another’s behalf may skew the
way risk is assessed [74]. Recent research from our lab has shown
that without training the dopamine system, losses are accentuated
even when trading for one’s own account [75]. Lastly, our findings
indicate that hiring more female traders may improve investment
company returns. Nonprofessional female investors tend to be
more risk-averse, trade less, and earn higher returns [76–78].
So, what makes a professional trader successful? Combining the
personality analyses and genetic findings from the present study,
reveals that our sample of traders are analytical, integrative, and
can delay gratification. They have a genetic profile associated with
balanced levels of dopamine, and also linked to moderate but not
high risk-taking behavior. Thus, successful traders do not appear
to take extraordinary risks and also appear to take a longer-term
perspective. Our analyses indicate that these traits may have a
genetic predisposition.
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